At a glance
ClinicalIndex Comparison RecordN/ACompleted· 246 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Real-world Data of Moderate to Severe Inflammatory Bowel Disease in Argentina: A Non-interventional, Multicenter Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life
In Brief
An observational study for Crohn Disease and 2 related conditions. Completed, enrolled 246 participants across 7 sites.
Detailed Summary
The purpose of this study is to evaluate the percentage of moderate to severe IBD participants with active disease at Day 1.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesArgentina
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedApr 2018
Enrollment StartDec 2018
Primary CompletionMay 2019
TodayJul 2026
First PostedApr 4, 2018
Enrollment StartDec 12, 2018
Primary CompletionMay 31, 2019
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 8.2 years ago